Abeona Therapeutics (ABEO) Tops Q1 EPS by 13c

Abeona Therapeutics (NASDAQ: ABEO) reported Q1 EPS of ($0.24), $0.13 better than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Kroger (KR) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY27 EPS Guidance
• Trilogy Metals closes $35.6M investment from U.S. Department of War